1,144
Views
0
CrossRef citations to date
0
Altmetric
Research Article

cfDNA Methylation in Liquid Biopsies as Potential Testicular Seminoma Biomarker

ORCID Icon, , , , , , , , , , , , , & show all
Pages 1493-1507 | Received 16 Sep 2022, Accepted 13 Jan 2023, Published online: 01 Feb 2023

References

  • Baroni T , AratoI , MancusoF , CalafioreR , LucaG. On the origin of testicular germ cell tumors: from gonocytes to testicular cancer. Front. Endocrinol.10(6), 1–8 (2019).
  • Leão R , AhmadAE , HamiltonRJ. Testicular cancer biomarkers: a role for precision medicine in testicular cancer. Clin. Genitourin. Cancer17(1), 176–183 (2019).
  • Van Casteren NJ , DeJong J , StoopHet al. Evaluation of testicular biopsies for carcinoma in situ: immunohistochemistry is mandatory. Int. J Androl.32(6), 666–674 (2009).
  • Looijenga LHJ , StoopH , BiermannK. Testicular cancer: biology and biomarkers. Virchows. Arch.464(3), 301–313 (2014).
  • Boccellino M , VanacoreD , ZappavignaSet al. Testicular cancer from diagnosis to epigenetic factors. Oncotarget8(61), 104654–104663 (2017).
  • Shen H , ShihJ , HollernDPet al. Integrated molecular characterization of testicular germ cell tumors. Cell. Rep.23(11), 3392–3406 (2018).
  • Das MK , KleppaL , HaugenTB. Functions of genes related to testicular germ cell tumour development. Andrology7(4), 527–535 (2019).
  • Bode PK , BarghornA , FritzscheFRet al. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors. Mod. Pathol.24(6), 829–835 (2011).
  • Raos D , UlamecM , KatusicBojanac A , Bulic-JakusF , JezekD , SincicN. Epigenetically inactivated RASSF1A as a tumor biomarker. Bosn. J. Basic Med. Sci.21(4), 386–397 (2020).
  • Raos D , KrasicJ , MasicSet al. In search of TGCT biomarkers: a comprehensive in silico and histopathological analysis. Dis. Markers2020(8841880), 1–18 (2020).
  • Lobo J , GillisAJM , JerónimoC , HenriqueR , LooijengaLHJ. Human germ cell tumors are developmental cancers: impact of epigenetics on pathobiology and clinic. Int. J. Mol. Sci.20(2), 1–28 (2019).
  • Koul S , MansukhaniM , MurtyVVet al. Characteristic promoter hypermethylation signatures in male germ cell tumors. Mol. Cancer1, 1–9 (2002).
  • Poulet G , MassiasJ , TalyV. Liquid biopsy: general concepts. Acta Cytol.63(6), 449–455 (2019).
  • Locke WJ , GuanzonD , MaCet al. DNA methylation cancer biomarkers: translation to the clinic. Front. Genet.10(11), 1–22 (2019).
  • Dieckmann KP , Simonsen-RichterH , KulejewskiMet al. Serum tumour markers in testicular germ cell tumours: frequencies of elevated levels and extents of marker elevation are significantly associated with clinical parameters and with response to treatment. Biomed. Res. Int.2019(5030349), 1–22 (2019).
  • Wei J , YinY , ZhouJet al. METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma. J. Cell. Mol. Med.24(19), 11366–11380 (2020).
  • Krasic J , AbramovicI , VrtaricAet al. Impact of preanalytical and analytical methods on cell-free DNA diagnostics. Front. Cell. Dev. Biol.9(686149), 1–17 (2021).
  • Abramovic I , VrhovecB , SkaraLet al. mir-182-5p and mir-375-3p have higher performance than PSA in discriminating prostate cancer from benign prostate hyperplasia. Cancers (Basel)13(9), 2068 (2021).
  • De la Rosa AH , ManoharanM , GoolamAS. Current concepts of epigenetics in testicular cancer. Indian J. Surg. Oncol.8(2), 169–174 (2017).
  • Li HG , HuangSY , ZhouH , LiaoAH , XiongCL. Quick recovery and characterization of cell-free DNA in seminal plasma of normozoospermia and azoospermia: implications for non-invasive genetic utilities. Asian J. Androl.11(6), 703–709 (2009).
  • Talukdar FR , AbramovićI , CueninCet al. A protocol for good quality genomic DNA isolation from formalin-fixed paraffin-embedded tissues without using commercial kits. Mol. Biol. Rep.49(5), 4115–4121 (2021).
  • Dahl AA , MykletunA , FossåSD. Quality of life in survivors of testicular cancer. Urol. Oncol.23(3), 193–200 (2005).
  • Kustanovich A , SchwartzR , PeretzT , GrinshpunA. Life and death of circulating cell-free DNA. Cancer Biol. Ther.20(8), 1057–1067 (2019).
  • Ehrlich Y , BeckSDW , FosterRS , BihrleR , EinhornLH. Serum tumor markers in testicular cancer. Urol. Oncol.31(1), 17–23 (2013).
  • Kawakami T , OkamotoK , OgawaO , OkadaY. XIST unmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer. Lancet363(9402), 40–42 (2004).
  • Ellinger J , AlbersP , PeraboFG , MüllerSC , Von RueckerA , BastianPJ. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. J. Urol.182(1), 324–329 (2009).
  • Medvedev KE , SavelyevaAV , ChenKS , BagrodiaA , JiaL , GrishinNV. Integrated molecular analysis reveals 2 distinct subtypes of pure seminoma of the testis. Cancer Inform.21, 1–15 (2022).
  • Hacioglu BM , KodazH , ErdoganBet al. K-RAS and N-RAS mutations in testicular germ cell tumors. Bosn. J. Basic Med. Sci.17(2), 159–163 (2017).
  • da Silva Martinelli CM , vanHelvoort Lengert A , CárcanoFMet al. MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients. Oncotarget8(31), 50608–50617 (2017).
  • Lobo J , Van ZogchelLMJ , NuruMGet al. Combining hypermethylated RASSF1A detection using ddPCR with miR-371a-3p testing: an improved panel of liquid biopsy biomarkers for testicular germ cell tumor patients. Cancers (Basel)13(20), 1–15 (2021).
  • Myklebust MP , ThorA , RosenlundBet al. Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study. Sci. Rep.11(1), 1–12 (2021).
  • Dieckmann KP , RadtkeA , GecziLet al. Serum levels of microRNA-371a-3p (M371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study. J. Clin. Oncol.37(16), 1412–1423 (2019).
  • Galow AM , PelegS. How to slow down the ticking clock: age-associated epigenetic alterations and related interventions to extend life span. Cells11(3), 468 (2022).
  • Lin Q , WeidnerCI , CostaIGet al. DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy. Aging (Albany NY)8(2), 394–401 (2016).
  • Biggs ML , DoodyDR , TrabertB , StarrJR , ChenCSS. Consumption of alcoholic beverages in adolescence and adulthood and risk of testicular germ cell tumor. Int. J. Cancer11(139), 2405–2414 (2016).
  • Srivastava A , KreigerN. Cigarette smoking and testicular cancer. Cancer Epidemiol. Biomarkers Prev.13(1), 49–54 (2004).
  • Nettersheim D , BiermannK , GillisAJM , StegerK , LooijengaLHJ , SchorleH. NANOG promoter methylation and expression correlation during normal and malignant human germ cell development. Epigenetics6(1), 114–122 (2011).
  • De Jong J , WeedaS , GillisAJM , OosterhuisJW , LooijengaLHJ. Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors. Oncol. Rep.18(1), 127–132 (2007).
  • Costa AL , Moreira-BarbosaC , LoboJet al. DNA methylation profiling as a tool for testicular germ cell tumors subtyping. Epigenomics10(12), 1511–1523 (2018).
  • Kemmer K , CorlessCL , FletcherJAet al. KIT mutations are common in testicular seminomas. Am. J. Pathol.164(1), 305–313 (2004).
  • Rodda DJ , ChewJL , LimLHet al. Transcriptional regulation of NANOG by OCT4 and SOX2. J. Biol. Chem.280(26), 24731–24737 (2005).
  • Corbetta M , ChiereghinC , DeSimone Iet al. Post-biopsy cell-free DNA from blood: an open window on primary prostate cancer genetics and biology. Front. Oncol.11(5), 1–10 (2021).
  • Bart J , GroenHJM , VanDer Graaf WTAet al. An oncological view on the blood–testis barrier. Lancet Oncol.3(6), 357–363 (2002).
  • Lind GE , SkotheimRI , LotheRA. The epigenome of testicular germ cell tumors. APMIS115(10), 1147–1160 (2007).
  • El Messaoudi S , RoletF , MouliereF , ThierryAR. Circulating cell free DNA: preanalytical considerations. Clin. Chim. Acta424, 222–230 (2013).
  • Murray MJ , WatsonHL , WardDet al. “Future-proofing” blood processing for measurement of circulating miRNAs in samples from biobanks and prospective clinical trials. Cancer Epidemiol. Biomarkers Prev.27(2), 208–218 (2018).
  • Constâncio V , TavaresNT , HenriqueR , JerónimoC , LoboJ. miRNA biomarkers in cancers of the male reproductive system: are we approaching clinical application?Andrology1–17doi:10.1111/andr.13258 (2022).
  • Glinge C , ClaussS , BoddumKet al. Stability of circulating blood-based microRNAs – pre-analytic methodological considerations. PLOS ONE12(2), 1–16 (2017).
  • Myklebust MP , RosenlundB , GjengstøPet al. Quantitative PCR measurement of miR-371a-3p and miR-372-p is influenced by hemolysis. Front. Genet.10(5), 1–9 (2019).
  • Timmerman DM , GillisAJM , MegoM , LooijengaLHJ. Comparative analyses of liquid-biopsy microRNA371a-3p isolation protocols for serum and plasma. Cancers (Basel)13(17), 1–15 (2021).
  • Gosselt HR , GriffioenPH , Van ZelstBD , OosteromN , DeJonge R , HeilSG. Global DNA (hydroxy)methylation is stable over time under several storage conditions and temperatures. Epigenetics16(1), 1–9 (2020).
  • Szklarczyk D , GableAL , NastouKCet al. The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res.49(D1), D605–D612 (2021).